CHE vs PSA · P/E 24, rev $2.43B vs rev $4.82B
Chemed Corp (CHE) versus PSA (PSA) — a side-by-side from cached financials, not a winner call.
Chemed Corp (CHE) is a medical care facilities company listed on NYSE.
PSA (PSA) common stock.
Latest reported CHE revenue for 2024-12-31 was $2.43B. Net income was $302.0M. Revenue was up 7.4% from 2023-12-31 to 2024-12-31. CHE currently screens at market cap $5.79B and trailing P/E 23.8.
Latest reported PSA revenue for 2025-12-31 was $4.82B. Net income was $1.78B. Revenue was up 2.7% from 2024-12-31 to 2025-12-31. PSA currently screens at market cap $0.
CHE currently screens at market cap $5.79B and trailing P/E 23.8. PSA currently screens at market cap $0.
Not investment advice. Open the CHE and PSA stock pages for the full models.
Not investment advice.